BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3863704)

  • 1. Synergistic anticellular effect of a combination of beta-interferon and retinoic acid against U937 cells.
    Ho CK
    Cancer Res; 1985 Nov; 45(11 Pt 1):5348-51. PubMed ID: 3863704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
    Kohlhepp EA; Condon ME; Hamburger AW
    Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.
    Widschwendter M; Daxenbichler G; Bachmair F; Müller E; Zeimet AG; Windbichler G; Uhl-Steidl M; Lang T; Marth C
    Anticancer Res; 1996; 16(1):369-74. PubMed ID: 8615638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937.
    Taimi M; Defacque H; Commes T; Favero J; Caron E; Marti J; Dornand J
    Immunology; 1993 Jun; 79(2):229-35. PubMed ID: 8344702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells.
    Hamburger AW; White CP; Siebenlist RE; Sedmak JJ; Grossberg SE
    Cancer Res; 1985 Nov; 45(11 Pt 1):5369-73. PubMed ID: 2996760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.
    Gullberg U; Nilsson E; Einhorn S; Olsson I
    Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells.
    Tan YY; Epstein LB; Armstrong RD
    Cancer Res; 1989 Aug; 49(16):4431-4. PubMed ID: 2743331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line.
    Buessow SC; Gillespie GY
    J Biol Response Mod; 1984 Dec; 3(6):653-62. PubMed ID: 6439829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H; Ratnam M
    Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
    Lingen MW; Polverini PJ; Bouck NP
    Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.
    Olsson IL; Breitman TR; Gallo RC
    Cancer Res; 1982 Oct; 42(10):3928-33. PubMed ID: 6286101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
    Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
    Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
    Dawson MJ; Trapani JA
    J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
    Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
    Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.